Literature DB >> 6388104

Hemodynamic effects of a competitive renin inhibitory peptide in humans: evidence for multiple mechanisms of action.

R M Zusman, J Burton, D Christensen, J Nussberger, A Dodds, E Haber.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6388104

Source DB:  PubMed          Journal:  Trans Assoc Am Physicians        ISSN: 0066-9458


× No keyword cloud information.
  7 in total

1.  'First dose' hypotension and venodilatation.

Authors:  S Capewell; A Capewell
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

2.  Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension.

Authors:  A H van den Meiracker; P J Admiraal; A J Man in 't Veld; F H Derkx; H J Ritsema van Eck; P Mulder; P van Brummelen; M A Schalekamp
Journal:  BMJ       Date:  1990-07-28

3.  Assessment of the role of the renin-angiotensin system in cardiac contractility utilizing the renin inhibitor remikiren.

Authors:  J P van Kats; L M Sassen; A H Danser; M P Polak; L K Soei; F H Derkx; M A Schalekamp; P D Verdouw
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

Review 4.  Renin inhibition.

Authors:  H D Kleinert
Journal:  Cardiovasc Drugs Ther       Date:  1995-10       Impact factor: 3.727

Review 5.  Clinical pharmacokinetics and efficacy of renin inhibitors.

Authors:  G A Rongen; J W Lenders; P Smits; T Thien
Journal:  Clin Pharmacokinet       Date:  1995-07       Impact factor: 6.447

Review 6.  The clinical potential of renin inhibitors and angiotensin antagonists.

Authors:  R J Cody
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

Review 7.  Haemodynamic responses to specific renin-angiotensin inhibitors in hypertension and congestive heart failure. A review.

Authors:  R J Cody
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.